ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation headquartered in Newark, New York, filed this Current Report on Form 8-K on May 8, 2026. The filing serves to announce the financial results for the first quarter ended March 31, 2026, via a press release incorporated as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are detailed in the attached press release (Exhibit 99.1), which is referenced but not included in the source text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
This 8-K filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is expected to be contained within the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 8, 2026) for specific Q1 2026 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2026 guidance provided in the press release.
- Confirm the absence of any material adverse events or legal contingencies in the full press release text.